| Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national … E Dolmazashvili, A Abutidze, N Chkhartishvili, M Karchava, L Sharvadze, ... European journal of gastroenterology & hepatology 29 (11), 1223-1230, 2017 | 96 | 2017 |
| Three years of progress toward achieving hepatitis C elimination in the country of Georgia, April 2015–March 2018 T Tsertsvadze, A Gamkrelidze, N Chkhartishvili, A Abutidze, L Sharvadze, ... Clinical Infectious Diseases 71 (5), 1263-1268, 2020 | 42 | 2020 |
| Late presentation of HIV infection in the country of Georgia: 2012-2015 N Chkhartishvili, O Chokoshvili, N Bolokadze, M Tsintsadze, L Sharvadze, ... PLoS One 12 (10), e0186835, 2017 | 25 | 2017 |
| Characterization of HIV‐1 subtypes and drug resistance mutations among individuals infected with HIV in Georgia N Dvali, MM Parker, N Chkhartishvili, L Sharvadze, N Gochitashvili, ... Journal of medical virology 84 (7), 1002-1008, 2012 | 20 | 2012 |
| The natural history of recent hepatitis C virus infection among blood donors and injection drug users in the country of Georgia T Tsertsvadze, L Sharvadze, N Chkhartishvili, L Dzigua, M Karchava, ... Virology journal 13, 1-7, 2016 | 16 | 2016 |
| Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors. N Badridze, N Chkhartishvili, A Abutidze, L Gatserelia, L Sharvadze Georgian medical news, 54-60, 2008 | 15 | 2008 |
| Outcomes of universal access to antiretroviral therapy (ART) in Georgia T Tsertsvadze, N Chkhartishvili, L Sharvadze, N Dvali, O Chokoshvili, ... AIDS research and treatment 2011 (1), 621078, 2011 | 13 | 2011 |
| Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia T Tsertsvadze, A Gamkrelidze, M Nasrullah, L Sharvadze, J Morgan, ... BMC Infectious Diseases 20, 1-7, 2020 | 12 | 2020 |
| Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program M Karchava, N Chkhartishvili, L Sharvadze, A Abutidze, N Dvali, ... Hepatology Research 48 (1), 36-44, 2018 | 11 | 2018 |
| Prevention of mother-to-child transmission of HIV: the Georgian experience T Tsertsvadze, T Kakabadze, K Shermadini, A Abutidze, M Karchava, ... Central european journal of public health 16 (3), 128-133, 2008 | 11 | 2008 |
| Incidence of tuberculosis among HIV/HCV coinfected patients receiving hepatitis C treatment with pegylated interferon and ribavirin in Georgia A Abutidze, N Bolokadze, N Chkhartishvili, L Sharvadze, T Tsertsvadze Georgian medical news, 10, 2016 | 8 | 2016 |
| Fibroscan and FibroTest/FibroMax to assess liver fibrosis/cirrhosis in patients with chronic HBV and HCV infection in Georgia. E Dolmazashvili, M Zhamutashvili, M Svanidze, N Nizharadze, A Abutidze Georgian Medical News, 83-87, 2008 | 7 | 2008 |
| Effect of remdesivir on mortality and the need for mechanical ventilation among hospitalized patients with COVID-19: real-world data from a resource-limited country R Metchurtchlishvili, N Chkhartishvili, A Abutidze, M Endeladze, ... International Journal of Infectious Diseases 129, 63-69, 2023 | 6 | 2023 |
| Comparative study of FIB-4 index and transient elastography among patients with chronic hepatitis C virus infection in Georgia E Dolmazashvili, M Karchava, A Abutidze, T Tsertsvadze Maia, 2019 | 6 | 2019 |
| Late HIV diagnosis in Georgia: public health and economic implications N Chkhartishvili, L Sharvadze, P Gabunia, A Abutidze, M Nikolaishvili, ... Translational and Clinical Medicine-Georgian Medical Journal 1 (1), 11-14, 2016 | 6 | 2016 |
| Significant improvements are needed in HIV care continuum to meet 90-90-90 targets in Georgia N Chkhartishvili, O Chokoshvili, N Dvali, A Abutidze, L Sharvadze, ... Journal of the International Association of Providers of AIDS Care (JIAPAC …, 2016 | 5 | 2016 |
| Assessment of liver fibrosis and cirrhosis by transient elastography among patients with chronic HBV and HCV infection in Georgia. T Tsertsvadze, E Dolmazashvili, A Abutidze, L Sharvadze, M Karchava Georgian Medical News, 38-42, 2008 | 5 | 2008 |
| SARS-cov-2 antibody seroprevalence in tbilisi, the capital city of country of georgia T Tsertsvadze, L Gatserelia, M Mirziashvili, N Dvali, A Abutidze, ... medRxiv, 2020.09. 18.20195024, 2020 | 4 | 2020 |
| HCV reinfection among HIV patients after DAA therapy in the country of Georgia N Chkhartishvili, P Gabunia, A Abutidze, G Korkotashvili, O Chokoshvili, ... The annual Conference on Retroviruses and Opportunistic Infections (CROI), 8-11, 2020 | 4 | 2020 |
| Progress toward achieving the UNAIDS 90-90-90 goals in HIV care from diagnosis to durable viral suppression in the country of Georgia N Chkhartishvili, O Chokoshvili, A Abutidze, N Dvali, C Del Rio, ... AIDS Research and Human Retroviruses 33 (10), 999-1003, 2017 | 4 | 2017 |
